Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger H Brookes

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Human Vaccines & Immunotherapeutics|January 10, 2014
Screening vaccine formulations for biological activity using fresh human whole bloodRoger H Brookes, Jalil Hakimi, Yukyung Ha, et al.
Vaccine|November 21, 2007
The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-gamma producing cells ex vivoMartin O C Ota, Roger H Brookes, Philip C Hill, et al.
The Lancet. Infectious Diseases|July 28, 2006
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study designHannah B Ibanga, Roger H Brookes, Philip C Hill, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
<i>Mycobacterium tuberculosis</i> Infection in Close Childhood Contacts of Adults with Pulmonary Tuberculosis is Increased by Secondhand Exposure to TobaccoIfedayo M O Adetifa, Lindsay Kendall, Simon Donkor, et al.
The Journal of Infectious Diseases|January 16, 2008
Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppressionAbdulrahman S Hammond, Samuel J McConkey, Philip C Hill, et al.
BMC Infectious Diseases|April 1, 2006
Reversion of the ELISPOT test after treatment in Gambian tuberculosis casesAlexander M Aiken, Philip C Hill, Annette Fox, et al.
Plos One|December 22, 2006
Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The GambiaPhilip C Hill, Roger H Brookes, Annette Fox, et al.
Human Vaccines & Immunotherapeutics|July 9, 2016
A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challengeMartina M Ochs, Kimberley Williams, Anthony Sheung, et al.
Communications Biology|August 8, 2020
Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicitySalvador F Ausar, Shaolong Zhu, Jessica Duprez, et al.
Human Vaccines & Immunotherapeutics|March 18, 2024
Formulation development of a stable influenza recombinant neuraminidase vaccine candidateBing Li, Irina V Ustyugova, Lisa Szymkowicz, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Human Vaccines & Immunotherapeutics|January 10, 2014
Screening vaccine formulations for biological activity using fresh human whole bloodRoger H Brookes, Jalil Hakimi, Yukyung Ha, et al.
Vaccine|November 21, 2007
The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-gamma producing cells ex vivoMartin O C Ota, Roger H Brookes, Philip C Hill, et al.
The Lancet. Infectious Diseases|July 28, 2006
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study designHannah B Ibanga, Roger H Brookes, Philip C Hill, et al.
The American Journal of Tropical Medicine and Hygiene|July 20, 2017
<i>Mycobacterium tuberculosis</i> Infection in Close Childhood Contacts of Adults with Pulmonary Tuberculosis is Increased by Secondhand Exposure to TobaccoIfedayo M O Adetifa, Lindsay Kendall, Simon Donkor, et al.
The Journal of Infectious Diseases|January 16, 2008
Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppressionAbdulrahman S Hammond, Samuel J McConkey, Philip C Hill, et al.
BMC Infectious Diseases|April 1, 2006
Reversion of the ELISPOT test after treatment in Gambian tuberculosis casesAlexander M Aiken, Philip C Hill, Annette Fox, et al.
Plos One|December 22, 2006
Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The GambiaPhilip C Hill, Roger H Brookes, Annette Fox, et al.
Human Vaccines & Immunotherapeutics|July 9, 2016
A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challengeMartina M Ochs, Kimberley Williams, Anthony Sheung, et al.
Communications Biology|August 8, 2020
Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicitySalvador F Ausar, Shaolong Zhu, Jessica Duprez, et al.
Human Vaccines & Immunotherapeutics|March 18, 2024
Formulation development of a stable influenza recombinant neuraminidase vaccine candidateBing Li, Irina V Ustyugova, Lisa Szymkowicz, et al.
Pageof 4